Pharming Group N.V.
PHGUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $675,027 | $796,028 | $748,814 | $532,118 |
| - Cash | $54,944 | $61,741 | $207,342 | $191,725 |
| + Debt | $112,313 | $171,545 | $166,694 | $161,593 |
| Enterprise Value | $732,396 | $905,832 | $708,166 | $501,986 |
| Revenue | $297,200 | $245,316 | $205,622 | $189,853 |
| % Growth | 21.1% | 19.3% | 8.3% | – |
| Gross Profit | $239,986 | $220,104 | $186,928 | $169,670 |
| % Margin | 80.7% | 89.7% | 90.9% | 89.4% |
| EBITDA | $13,642 | $9,877 | $33,533 | $48,779 |
| % Margin | 4.6% | 4% | 16.3% | 25.7% |
| Net Income | -$11,332 | -$10,769 | $13,674 | $15,996 |
| % Margin | -3.8% | -4.4% | 6.7% | 8.4% |
| EPS Diluted | -0.017 | -0.015 | 0.019 | 0.023 |
| % Growth | -12.7% | -178.9% | -17.4% | – |
| Operating Cash Flow | -$1,795 | -$17,302 | $22,897 | $36,126 |
| Capital Expenditures | -$756 | -$1,464 | -$1,977 | -$15,958 |
| Free Cash Flow | -$6,723 | -$18,766 | $20,920 | $20,168 |